azelastine hcl nasal
- Product NDC
- 45802-026
- 11-digit product format
- 458020026
- Labeler code
- 45802
- Product ID
- 45802-026_13a7f4f6-f9ad-4072-a70b-b80c4c24059f
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Azelastine HCl
- Dosage form
- SPRAY
- Route
- NASAL
- Labeler
- Padagis Israel Pharmaceuticals Ltd
- Application
- ANDA202743
- Marketing category
- ANDA
- Marketing start
- 2014-05-09
- Marketing end
- 0000-00-00
- Substance
- AZELASTINE HYDROCHLORIDE
- Active strength
- 206 ug/1
- Pharmacologic classes
- Histamine H1 Receptor Antagonists [MoA],Histamine-1 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 45802-026-83 | 45802002683 | 1 BOTTLE in 1 CARTON (45802-026-83) > 200 SPRAY in 1 BOTTLE | 1 bottle | 2014-05-09 | 0000-00-00 | No | No | Current |